Willner Antonie, Bogner Andreas, Müssle Benjamin, Teske Christian, Hempel Sebastian, Kahlert Christoph, Distler Marius, Weitz Jürgen, Welsch Thilo
Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Medicine (Baltimore). 2020 Oct 30;99(44):e22896. doi: 10.1097/MD.0000000000022896.
Many patients with chronic pancreatitis (CP) undergo a step-up approach with interventional procedures as first-line treatment and resection reserved for later stages. The aim of this study was to identify predictive factors for a significant clinical improvement (SCI) after surgical treatment.All patients operated for CP between September 2012 and June 2017 at our center was retrospectively reviewed. A prospective patient survey was conducted to measure patients postoperative outcome. The primary endpoint SCI was defined as stable health status, positive weight development and complete pain relief without routine pain medication. Additionally, risk factors for relaparotomy were analyzed.A total of 89 patients with a median follow-up of 38 months were included. In most cases, a duodenum-preserving pancreatic head resection (n = 48) or pancreatoduodenectomy (n = 28) was performed. SCI was achieved in 65.3% (n = 47) of the patients after the final medium follow-up of 15.0 months (IQR: 7.0-35.0 months), respectively. Patients with a longer mean delay (7.7 vs 4 years) between diagnosis and surgical resection were less likely to achieve SCI (P = .02; OR .88; 95%CI .80-98). An endocrine insufficiency was a negative prognostic factor for SCI (P = .01; OR .15; 95%CI .04-68). In total, 96.2% of the patients had a complete or major postoperative relief with a mean pain intensity reduction from 8.1 to 1.9 on the visual analogue scale.The results support that surgical resection for CP should be considered at early stages. Resection can effectively reduce postoperative pain intensity and improve long-term success.
许多慢性胰腺炎(CP)患者采用逐步升级的治疗方法,将介入手术作为一线治疗手段,而将切除术留待后期阶段。本研究的目的是确定手术治疗后显著临床改善(SCI)的预测因素。
对2012年9月至2017年6月在我们中心接受CP手术的所有患者进行了回顾性研究。进行了一项前瞻性患者调查以评估患者的术后结果。主要终点SCI定义为健康状况稳定、体重呈正向增长且无需常规止痛药物即可完全缓解疼痛。此外,还分析了再次剖腹手术的危险因素。
共纳入89例患者,中位随访时间为38个月。在大多数情况下,实施了保留十二指肠的胰头切除术(n = 48)或胰十二指肠切除术(n = 28)。在最终中位随访15.0个月(四分位间距:7.0 - 35.0个月)后,65.3%(n = 47)的患者实现了SCI。诊断与手术切除之间平均延迟时间较长(7.7年对4年)的患者实现SCI的可能性较小(P = 0.02;比值比0.88;95%置信区间0.80 - 0.98)。内分泌功能不全是SCI的不良预后因素(P = 0.01;比值比0.15;95%置信区间0.04 - 0.68)。总体而言,96.2%的患者术后疼痛完全或大幅缓解,视觉模拟量表上的平均疼痛强度从8.1降至1.9。
结果表明,CP的手术切除应在早期阶段考虑。切除可有效降低术后疼痛强度并提高长期成功率。